Objective
This study sought to use claims data to determine the utilization rates of genetic testing in patients seen by a neurologist within a large private insurance population.
Conclusion
Results indicated that accurate assessment of genetic testing utilization using claims data is not possible given the high prevalence of nonspecific codes. Reducing the ambiguity surrounding the Current Procedural Terminology codes and the actual testing performed will become even more important as more genetic tests become available.